Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dynein axonemal assembly factor 11 (DNAAF11, previously known as LRRC6) is a cytoplasmic protein characterized by multiple leucine-rich repeat (LRR) domains[3][9]. It is essential for the assembly and cytoplasmic trafficking of outer dynein arm proteins, which are subsequently incorporated into cilia and flagella[3][5][6][9]. DNAAF11 acts as a crucial assembly factor for motile cilia and is required for proper ciliary and flagellar beating, particularly in airway epithelia and sperm[3][9]. Pathogenic variants in the DNAAF11 gene cause primary ciliary dyskinesia-19 (CILD19), an autosomal recessive disorder characterized by impaired ciliary motility, leading to chronic respiratory tract infections, laterality defects, and infertility[1][3][8][9]. DNAAF11 is not a therapeutic target but is of diagnostic importance for ciliopathies, especially to identify genetic causes of primary ciliary dyskinesia[1][3][8][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dynein axonemal assembly factor 11 (DNAAF11).